0001104659-20-124779.txt : 20201113
0001104659-20-124779.hdr.sgml : 20201113
20201113105258
ACCESSION NUMBER: 0001104659-20-124779
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20200930
FILED AS OF DATE: 20201113
DATE AS OF CHANGE: 20201113
EFFECTIVENESS DATE: 20201113
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foresite Capital Management II, LLC
CENTRAL INDEX KEY: 0001594912
IRS NUMBER: 464028844
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16497
FILM NUMBER: 201309794
BUSINESS ADDRESS:
STREET 1: 600 MONTGOMERY STREET
STREET 2: SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 415-877-4887
MAIL ADDRESS:
STREET 1: 600 MONTGOMERY STREET
STREET 2: SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001594912
XXXXXXXX
09-30-2020
09-30-2020
false
Foresite Capital Management II, LLC
600 Montgomery Street
Suite 4500
San Francisco
CA
94111
13F HOLDINGS REPORT
028-16497
N
James B. Tananbaum
Managing Member
415-877-4887
/s/ James B. Tananbaum
San Francisco
CA
11-13-2020
0
4
459571
INFORMATION TABLE
2
infotable.xml
10x Genomics, Inc.
CLASS A COMMON
88025U109
436820
3503528
SH
SOLE
3503528
0
0
Acceleron Pharma Inc.
COM
00434H108
5163
45884
SH
SOLE
45884
0
0
Epizyme, Inc.
COM
29428V104
10288
862402
SH
SOLE
862402
0
0
Novavax, Inc.
COM
670002401
7300
67373
SH
SOLE
67373
0
0